The Pac-12 today announced a conference-wide surveillance testing partnership for SARS-CoV-2 (COVID-19) with Fulgent Genetics as part of its on-going student-athlete health & well-being initiative’s efforts.
Under the partnership, Fulgent Genetics will provide RT-PCR (reverse transcription polymerase chain reaction) testing capabilities to supplement existing PCR and antigen testing capabilities across each Pac-12 athletics department.
The partnership follows and is in addition to the Pac-12’s recently announced partnership with Quidel Corporation for daily rapid-results testing capabilities (point-of-care).
“We are excited to be partnering with a leading testing company in Fulgent to provide our athletic departments with the very best capabilities to protect the health and well-being of our student-athletes,” said Pac-12 Commissioner Larry Scott. “On the heels of our agreement with Quidel to provide rapid-results testing, today’s announcement represents another important step in providing a safe and healthy environment for a return to competition for our student-athletes.”
Dr. Doug Aukerman, senior associate athletics director for Oregon State and chair of the Pac-12 SAHWBI added: “Providing additional resources at the level of what Fulgent Genetics offers is a tremendous addition for our athletics departments and staff as we continue to strive for the most secure and safe environment for our student-athletes’ return to play.”
“Routine, rapid testing is playing a key role in limiting the spread of COVID-19 and is helping to keep players, coaches and staff safe as they look to return to competition. The Pac-12 has implemented several protocols in this area, and the RT-PCR testing provided by Fulgent Genetics is an important part of this process,” said Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. “RT-PCR is regarded as the gold standard in COVID-19 testing, providing the highest level of sensitivity and specificity. At Fulgent, we have built technology platforms around our test to make it scalable for the Pac-12, which allows us to deliver results within 24 hours of receipt of the sample for testing. We are excited to partner with the Pac-12 and look forward to helping keep their athletic programs running safely.”
Each Pac-12 institution currently has RT-PCR testing practices and protocols in place for their athletics departments. With the new partnership, Fulgent Genetics will be able to serve as a supplemental resource for each athletics department. The RT-PCR testing program from Fulgent Genetics will be driven by the new Fulgent Enterprise COVID-19 Screening Platform, which provides an end-to-end solution for routine and repeat testing, including onsite testing for student-athletes and staff, 24-hour results and mobile delivery and interface.